Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Repisalud
Publication Tesis doctoral (DoctoralThesis)

Mechanisms involved in quiescent blood vessel homeostasis

  • Fernandez-Chacon, Macarena
Our vascular system is an organized and hierarchical blood vessel network lined by a monolayer of endothelial cells (ECs) that supplies oxygen and nutrients to all tissues and organs in our body. Importantly, they are not passive conduits for blood flow and they contribute to organ physiology and homeostasis throughout the entire life of the organisms. Therefore, it is not surprising that an imbalance of this vascular network is involved the pathogenesis of many diseases such as cancer, stroke or myocardial infarction. The Notch signalling pathway is a critical regulator in the process of angiogenesis, participating in the tip-stalk specification, arterial-venous differentiation, vessel stabilization and maturation. Importantly, pharmacological compounds targeting distinct members of the Notch signalling pathway have been used in the clinics but their effect on the homeostasis of different types of blood vessels is unknown. In this thesis, we have developed and used a wide range of novel genetic tools, loss-offunction mouse models, imaging, trancriptomic and proteomic approaches to uncover the role of several Notch signalling members in the regulation of organ-specific vascular homeostasis at high cellular and molecular resolution. We found that Dll4/Notch signalling is active in most quiescent endothelium of several organs, such as the heart, lung, liver and brain. However, despite being active in all the mentioned vascular tissues, only in heart and liver vessels it plays an essential role in the maintenance of vascular quiescence by actively repressing EC proliferation. By using comparative transcriptomic and proteomic approaches, we found that Dll4/Notch1 actively supresses the Myc pathway to sustain vascular quiescence in the liver. By analysing a series of Notch signalling mutants, we found that while loss of the ligand Dll4 leads to an intermediate increase in p-ERK levels and cell cycle entry, resulting in EC hyperproliferation; loss of the co-factor Rbpj or the receptor Notch1 induces even higher ERK signalling activity but not EC proliferation. At high p-ERK levels there is an increase in the expression of the cell cycle inhibitor p21, which arrests EC proliferation. These arrested cells have also several features of endothelial senescence. In addition, we observed that the loss of Dll4/Notch signalling in liver ECs, promotes the transient increase in the proliferation of neighboring hepatocytes prior to their own expansion, suggesting the existence of angiocrine factors secreted by ECs after the loss of Notch signalling. Moreover, the effect of Notch on liver endothelial cell proliferation was very heterogenous and zonated. ECs located close to the central veins had a higher proliferation potential compared to the endothelium located in oxygen-rich periportal zones. Using multispectral genetic mosaics, we also identified a rare population of liver ECs that is able to clonally expand more than most of their neighbours, suggesting the existence of liver-resident endothelial progenitor cells. In addition to these studies on the role of Notch in vascular biology, we also used and validated an inducible dual reporter-Cre mouse allele (iSuRe-Cre), which by significantly increasing Cre activity in reporter-expressing cells, it provides certainty that these cells have completely recombined floxed alleles.
Repisalud
Publication Artículo científico (JournalArticle)

Zebrafish mutants in vegfab can affect endothelial cell proliferation without altering ERK phosphorylation and are phenocopied by loss of PI3K signaling.

  • Lange, Martin
  • Ohnesorge, Nils
  • Hoffmann, Dennis
  • Rocha, Susana F
  • Benedito, Rui
  • Siekmann, Arndt F
The formation of appropriately patterned blood vessel networks requires endothelial cell migration and proliferation. Signaling through the Vascular Endothelial Growth Factor A (VEGFA) pathway is instrumental in coordinating these processes. mRNA splicing generates short (diffusible) and long (extracellular matrix bound) Vegfa isoforms. The differences between these isoforms in controlling cellular functions are not understood. In zebrafish, vegfaa generates short and long isoforms, while vegfab only generates long isoforms. We found that mutations in vegfaa had an impact on endothelial cell (EC) migration and proliferation. Surprisingly, mutations in vegfab more strongly affected EC proliferation in distinct blood vessels, such as intersegmental blood vessels in the zebrafish trunk and central arteries in the head. Analysis of downstream signaling pathways revealed no change in MAPK (ERK) activation, while inhibiting PI3 kinase signaling phenocopied vegfab mutant phenotypes in affected blood vessels. Together, these results suggest that extracellular matrix bound Vegfa might act through PI3K signaling to control EC proliferation in a distinct set of blood vessels during angiogenesis.
Repisalud
Publication Artículo científico (JournalArticle)

Endothelial sprouting, proliferation, or senescence: tipping the balance from physiology to pathology.

  • Mühleder, Severin
  • Fernandez-Chacon, Macarena
  • Garcia-Gonzalez, Irene
  • Benedito, Rui
Therapeutic modulation of vascular cell proliferation and migration is essential for the effective inhibition of angiogenesis in cancer or its induction in cardiovascular disease. The general view is that an increase in vascular growth factor levels or mitogenic stimulation is beneficial for angiogenesis, since it leads to an increase in both endothelial proliferation and sprouting. However, several recent studies showed that an increase in mitogenic stimuli can also lead to the arrest of angiogenesis. This is due to the existence of intrinsic signaling feedback loops and cell cycle checkpoints that work in synchrony to maintain a balance between endothelial proliferation and sprouting. This balance is tightly and effectively regulated during tissue growth and is often deregulated or impaired in disease. Most therapeutic strategies used so far to promote vascular growth simply increase mitogenic stimuli, without taking into account its deleterious effects on this balance and on vascular cells. Here, we review the main findings on the mechanisms controlling physiological vascular sprouting, proliferation, and senescence and how those mechanisms are often deregulated in acquired or congenital cardiovascular disease leading to a diverse range of pathologies. We also discuss alternative approaches to increase the effectiveness of pro-angiogenic therapies in cardiovascular regenerative medicine.